Roundup Lawsuit Settlement Talks: Everything You Need to Know

Roundup settlement talks

Reports surfaced early Friday that Bayer AG had proposed paying as much as $8 billion to settle more than 18,000 Roundup lawsuits in the United States. But attorney Ken Feinberg, mediator for the court-mandated settlement talks, told Reuters in an email that “such a statement is pure fiction.”

“Bayer has not proposed paying $8 billion to settle all the U.S. Roundup cancer claims,” said Feinberg, who was appointed as mediator back in May 2019 and instructed to meet with lawyers for Bayer and plaintiffs. “Compensation has not even been discussed in the global mediation discussions.”

Roundup lawsuits claim the popular glyphosate-based weed killer caused non-Hodgkin lymphoma, a type of cancer. They name Monsanto Co., the herbicide’s original manufacturer. Bayer acquired the company in 2018.

On Aug. 9, 2019, The New York Times reported that the number of U.S. lawsuits blaming glyphosate-based herbicides for causing cancer had risen by 5,000, bringing the total to 18,400 claims. More than 1,300 lawsuits over Roundup’s alleged cancer risks have been consolidated in a federal court in San Francisco, according to the U.S. Judicial Panel on Multidistrict Litigation’s July 2019 report.

So far, three juries have found that Monsanto should have warned of the alleged cancer risks from Roundup, and they ordered Bayer to pay a combined $2.37 billion. The jury awards have since been reduced but still total nearly $190 million.

Diagnosed with cancer after exposure to Roundup? Get a Free Case Review

Meanwhile, a trial scheduled to begin Aug. 19, 2019, in St. Louis has been delayed until January 2020. Lawyers for both sides asked a St. Louis judge to postpone a second trial as well. Experts say this indicates settlement talks are moving ahead.

Having three consecutive multimillion-dollar losses doesn’t look good for Bayer’s chances in future trials, experts say. Bayer Chief Executive Officer Werner Baumann has said that he’d consider a settlement if it were “financially reasonable.”

Lawyers for Bayer and for former Roundup users have been involved in ongoing talks in New York. Citing people familiar with the negotiations, Bloomberg reported that Bayer suggested paying $6 billion to $8 billion to resolve existing and future claims. But to drop their claims, plaintiffs’ lawyers reportedly want more than $10 billion.

The news organization later updated its report with a quote from Feinberg: “There have been absolutely no discussions to date of dollars or what compensation would be for a global resolution.”

It could take months for lawyers to reach an agreement about how to compensate people who used Roundup and have yet to be diagnosed with cancer.

Lawyers continue to accept new cases involving people who have developed non-Hodgkin lymphoma after being exposed to glyphosate, Roundup, or both. People who have lost a family member because of exposure to these herbicides may also be eligible for compensation.

  •  
  •  
  •  
Emily Miller
Written By Emily Miller Editor

Emily Miller is an award-winning journalist with 7 years of professional experience writing and editing content for reputable media organizations across the U.S. She also has 13 years of personal experience as a patient living with Crohn’s disease. Her coverage of U.S. prescription drug prices for Drugwatch has been published or cited by news outlets, including The Hill, Fox Business and United Press International. Some of her qualifications include:

  • Society of Professional Journalists and The Alliance of Professional Health Advocates member
  • Centers for Disease Control and Prevention Health Literacy certificates
  • 2016 Florida Society of News Editors third place winner in Breaking News
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(855) 402-1558